TCL Archive Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors October 31, 2014
TCL Archive In Congress: Conferees Approve 42 billion Increase For NIH Appropriations October 29, 1999
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
